These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 19969034
1. DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA. Mével M, Kamaly N, Carmona S, Oliver MH, Jorgensen MR, Crowther C, Salazar FH, Marion PL, Fujino M, Natori Y, Thanou M, Arbuthnot P, Yaouanc JJ, Jaffrès PA, Miller AD. J Control Release; 2010 Apr 19; 143(2):222-32. PubMed ID: 19969034 [Abstract] [Full Text] [Related]
2. Efficient topical delivery of plasmid DNA to lung in vivo mediated by putative triggered, PEGylated pDNA nanoparticles. Aissaoui A, Chami M, Hussein M, Miller AD. J Control Release; 2011 Sep 25; 154(3):275-84. PubMed ID: 21699935 [Abstract] [Full Text] [Related]
3. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Spagnou S, Miller AD, Keller M. Biochemistry; 2004 Oct 26; 43(42):13348-56. PubMed ID: 15491141 [Abstract] [Full Text] [Related]
4. Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation. Barichello JM, Ishida T, Kiwada H. Methods Mol Biol; 2010 Oct 26; 605():461-72. PubMed ID: 20072901 [Abstract] [Full Text] [Related]
5. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid. Kim HK, Davaa E, Myung CS, Park JS. Int J Pharm; 2010 Jun 15; 392(1-2):141-7. PubMed ID: 20347025 [Abstract] [Full Text] [Related]
7. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles. Carmona S, Jorgensen MR, Kolli S, Crowther C, Salazar FH, Marion PL, Fujino M, Natori Y, Thanou M, Arbuthnot P, Miller AD. Mol Pharm; 2009 Jun 15; 6(3):706-17. PubMed ID: 19159285 [Abstract] [Full Text] [Related]
8. Anionic amino acid-derived cationic lipid for siRNA delivery. Suh MS, Shim G, Lee HY, Han SE, Yu YH, Choi Y, Kim K, Kwon IC, Weon KY, Kim YB, Oh YK. J Control Release; 2009 Dec 16; 140(3):268-76. PubMed ID: 19567256 [Abstract] [Full Text] [Related]
9. Structure-transfection activity relationships in a series of novel cationic lipids with heterocyclic head-groups. Ivanova EA, Maslov MA, Kabilova TO, Puchkov PA, Alekseeva AS, Boldyrev IA, Vlassov VV, Serebrennikova GA, Morozova NG, Zenkova MA. Org Biomol Chem; 2013 Nov 07; 11(41):7164-78. PubMed ID: 24057052 [Abstract] [Full Text] [Related]
10. In vitro and in vivo gene-transferring characteristics of novel cationic lipids, DMKD (O,O'-dimyristyl-N-lysyl aspartate) and DMKE (O,O'-dimyristyl-N-lysyl glutamate). Kim HS, Song IH, Kim JC, Kim EJ, Jang DO, Park YS. J Control Release; 2006 Oct 10; 115(2):234-41. PubMed ID: 16989919 [Abstract] [Full Text] [Related]
11. In vitro lipofection with novel asymmetric series of 1,2-dialkoylamidopropane-based cytofectins containing single symmetric bis-(2-dimethylaminoethane) polar headgroups. Savva M, Chen P, Aljaberi A, Selvi B, Spelios M. Bioconjug Chem; 2005 Oct 10; 16(6):1411-22. PubMed ID: 16287237 [Abstract] [Full Text] [Related]
12. Biophysical properties of CDAN/DOPE-analogue lipoplexes account for enhanced gene delivery. Fletcher S, Ahmad A, Price WS, Jorgensen MR, Miller AD. Chembiochem; 2008 Feb 15; 9(3):455-63. PubMed ID: 18186098 [Abstract] [Full Text] [Related]
13. The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex. Tagami T, Barichello JM, Kikuchi H, Ishida T, Kiwada H. Int J Pharm; 2007 Mar 21; 333(1-2):62-9. PubMed ID: 17097247 [Abstract] [Full Text] [Related]
15. Liposomal magnetofection. Mykhaylyk O, Sánchez-Antequera Y, Vlaskou D, Hammerschmid E, Anton M, Zelphati O, Plank C. Methods Mol Biol; 2010 Mar 21; 605():487-525. PubMed ID: 20072903 [Abstract] [Full Text] [Related]
16. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug. Beh CW, Seow WY, Wang Y, Zhang Y, Ong ZY, Ee PL, Yang YY. Biomacromolecules; 2009 Jan 12; 10(1):41-8. PubMed ID: 19072631 [Abstract] [Full Text] [Related]
17. Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA. Han SE, Kang H, Shim GY, Suh MS, Kim SJ, Kim JS, Oh YK. Int J Pharm; 2008 Apr 02; 353(1-2):260-9. PubMed ID: 18178348 [Abstract] [Full Text] [Related]
19. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes. Ramezani M, Khoshhamdam M, Dehshahri A, Malaekeh-Nikouei B. Colloids Surf B Biointerfaces; 2009 Aug 01; 72(1):1-5. PubMed ID: 19395245 [Abstract] [Full Text] [Related]
20. Efficient gene transfection by bisguanylated diacetylene lipid formulations. Patel M, Vivien E, Hauchecorne M, Oudrhiri N, Ramasawmy R, Vigneron JP, Lehn P, Lehn JM. Biochem Biophys Res Commun; 2001 Feb 23; 281(2):536-43. PubMed ID: 11181080 [Abstract] [Full Text] [Related] Page: [Next] [New Search]